Quantifying biotherapeutics in biological matrices plays a critical role in the drug discovery and development process. Ligand binding assays often lack the sensitivity to detect low-concentration analytes, particularly with limited sample supply. Scientists in bioanalytical laboratories routinely use liquid chromatography with tandem mass spectrometry (LC-MSMS) to complement traditional ligand binding assays.
In this webinar sponsored by SCIEX, Lei Xiong will discuss how SCIEX’s Triple Quad™ 7500 LC-MS/MS System improves assay sensitivity for in-matrix quantification of various types of biotherapeutics, including monoclonal antibodies, cyclic peptides, and oligonucleotides.
Topics to be covered
Speaker Information:
Lei Xiong, PhD
Biopharma application manager, North America
SCIEX
Drug Discovery News
1000 N West Street | Wilmington | Delaware | 19801 | US
Email: privacy@drugdiscoverynews.com
© 2021 Old River Publications LLC. All rights reserved
Drug Discovery News needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy